Journal
JOURNAL OF LAW MEDICINE & ETHICS
Volume 36, Issue 2, Pages 219-248Publisher
SAGE PUBLICATIONS INC
DOI: 10.1111/j.1748-720X.2008.00266.x
Keywords
-
Categories
Funding
- NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003178] Funding Source: NIH RePORTER
- NHGRI NIH HHS [R01 HG 003178, R01 HG003178-01A1, R01 HG003178] Funding Source: Medline
Ask authors/readers for more resources
No consensus yet exists on how to handle incidental findings (IFs) in human subjects research. Yet empirical studies document IFs in a wide range of research studies, where IFs are findings beyond the aims of the study that are of potential health or reproductive importance to the individual research participant. This paper reports recommendations of a two-year project group funded by NIH to study how to manage IFs in genetic and genomic research, as well as imaging research. We conclude that researchers have an obligation to address the possibility of discovering IFs in their protocol and communications with the IRB, and in their consent forms and communications with research participants. Researchers should establish a pathway for handling IFs and communicate that to the IRB and research participants. We recommend a pathway and categorize IFs into those that must be disclosed to research participants, those that may be disclosed, and those that should not be disclosed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available